미국 · 보도자료 · VALNEVA SE · 2026-10-07 20:00
영국 내 IXCHIQ® 백신 관련 최신 진행 상황 발표
Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ ® for travelers by the United Kingdom’s (UK) Commission on Human Medicines (CHM), the UK marketing authorization for IXCHIQ ® has been revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). The
